Website stats for Biospectator - biospectator.com
, 大 ' AI' (Deep bio) (Software License Agreement) . . (AI) ‘DeepDx Prostate’ DeepDx Prostate . , 'mRNA' ...
biospectator.com was registered 8 years 8 months ago. It has a alexa rank of #259,843 in the world. It is a domain having .com extension. It is estimated worth of $ 35,640.00 and have a daily income of around $ 66.00. As no active threats were reported recently, biospectator.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 5,905 |
| Daily Pageviews: | 23,620 |
Estimated Valuation
| Income Per Day: | $ 66.00 |
| Estimated Worth: | $ 35,640.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 259,843 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
112.175.173.118
Hosted Country:
KR
Location Latitude:
37.5683Location Longitude:
126.978Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | No Data |
| Referral Traffic: | No Data |
| Search Traffic: | No Data |
| Social Traffic: | No Data |
| Mail Traffic: | No Data |
| Display Traffic: | No Data |
Search Engine Results For biospectator.com
News and Publications - 이뮨온시아
[Korean News] http://www.biospectator.com/view/news_view.php?varAtcId= 10394. By immun| 2020-05-22T10:34:04+00:00 2020/05/22|Categories: News and ...
NEROVIS - NEUROVIS
MOU Conclusion of Agreement (우정바이오). (2019.11.04) 우정바이오 MOU Conclusion of Agreement @SB플라자 http://m.biospectator.com/view/ ...
Mitoimmune Targets Intractable Respiratory Diseases Using Anti ...
http://www.biospectator.com/view/news_view.php?varAtcId=8194 618회 연결. 목록 · 이전글 미토콘드리아, T세포 활성화로 면역항암제 '부스터'될까 · 다음글 LG ...
AMYLOID SOLUTION
https://www.sedaily.com/NewsView/1ZA93ZLYWQ · http://www.medigatenews. com/news/617525746 · http://www.biospectator.com/view/news_view.php?
DCGEN
기사링크: http://www.biospectator.com/view/news_view.php?varAtcId=9142. Read more · 2019-12-26 디시젠 "NGS로 RNA 발현 분석..新유방암 예후진단". 디시젠 ...
'NIPT diagnostic kit' SeasuBiomaterials, selected as the lead ...
Jan 26, 2021 ... http://www.biospectator.com/view/news_view.php?varAtcId=3193 · http://www. astinet.kr/front/welcome/weekly/retrieve.do?boardSeq=16564.
BioSpectator > BRIC
언론 http://www.biospectator.com/view/news_view.php?varAtcId=10343 펍피어 https://pubpeer.com/publications/5D032AA212AE4FA9BB2B322BCA756C ...
Howard – Yuhan USA
... of a cell line and the sample drugs for animal and human tests. Related Article from Biospectator (Korean): http://m.biospectator.com/view/news_view.php?
Newspaper article on CAIDE Systems - CAIDE Systems
Jul 16, 2018 ... Biospectator, a respected life science focused newspaper in South Korea, published an article on CAIDE Systems. The article talks about the ...
pH Pharma signed a collaboration and licensing agreement for ADC ...
Dec 17, 2019 ... http://www.biospectator.com/view/news_view.php?varAtcId=9127. Back. Back. pH Pharma. Copyright © 2021 pH Pharma | All Rights Reserved.
바이오스펙테이터
국내/외 바이오 기업 이슈 및 정책, 전문가 인터뷰 및 기고 제공.
KYNOGEN Corp. - 카이노젠
BioSpectator has published a report on the KYNOGEN's business. For the full text art... Read More ...
Deep Bio launches AI-diagnostic software on prostate cancer
Dec 13, 2018 ... Biospectator. ios-image. Deep Bio announced today that it had released its artificial intelligence (AI) diagnostic products for the first time in the ...
(주)바이오스펙테이터 2021년 기업정보 | 회사소개, 근무환경, 복리 ...
Dec 9, 2020 ... 업종: 데이터베이스 및 온라인정보 제공업; 대표자명: 이기형; 홈페이지: http:// biospectator.com; 기업주소: 서울 영등포구 여의대방로69길23, 6층 ...
카이팜(Kaipharm) Jobs and Careers | Wanted
카이팜, 50억 유치.."NGS 약물-전사체 빅데이터 구축" - 바이오스펙테이터. m. biospectator.com 2020.1.29. logo. Terms of UsePrivacy PolicyFAQ. country flag WW.
NEWS | EOFLOW
Sep 7, 2017 ... http://www.viva100.com/main/view.php?key=20170906020020830 · http:// biospectator.com/view/news_view.php?varAtcId=3950.
(주)카나프테라퓨틱스 - NEWS - NEWS
카나프, 'TME 활성화' 투트랙 전략 "선택한 이유". PRESS: Admin; DATE: 2020-11- 19; HIT: 572. http://www.biospectator.com/view/news_view.php?varAtcId=11696.
Analysis and Estimation for Market Share of Biologics based on ...
Bae, E.Y., Determinants of drug market share, The Korean Journal of Health Economics and Policy, 2000, Vol. 6, No. 2, pp. 1-30. BIOSPECTATOR, http://www .
바이오 뉴스 < 사업정보 - 바이오아고라
Jun 25, 2021 ... http://www.biospectator.com/view/news_view.php?varAtcId=13524. ◇ 파로스아이바이오, 180억 규모 시리즈C 투자유치 완료. - 누적 기관투자자 ...
뉴플라이트 채용 | 원티드
뉴플라이트-365mc, 지방줄기세포 JV '모닛셀' 론칭 - 바이오스펙테이터. m. biospectator.com 2019.12.19. logo. 기업소개이용약관개인정보 처리방침고객센터.
미국 GRAS 안전성 인증 > 항산화효소 SOD | (주)제노포커스 쇼핑몰
GRAS는 식품수준으로 먹을 수 있는 안전한 물질이라는 의미로써 국내개발 효소로는 최초로 미국 GRAS 인증을 받은 것이다. http://www.biospectator.com/view/ ...
href:http://www.biospectator.com/view/news_view.php?varAtcId=8209
href:http://www.biospectator.com/view/news_view.php?varAtcId=8209에 대해 riaakim이(가) 작성한 글.
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | 1 |
| H3 Headings: | 4 | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 27 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-79852016-1 |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| 성영철 회장 | 2 | 0.873 % | No |
| 제넥신 성영철 | 2 | 0.873 % | No |
| 회장 대표·이사회서 | 2 | 0.873 % | No |
| 대표·이사회서 물러난다 | 2 | 0.873 % | No |
| 적용 PDC | 2 | 0.873 % | No |
| 고군분투 아이오니스 | 2 | 0.873 % | No |
| 계획이다 또 | 2 | 0.873 % | No |
| 셀트리온 ECCMID서 | 2 | 0.873 % | No |
| 결과 구두발표 | 2 | 0.873 % | No |
| 아이오니스 Bicycle | 2 | 0.873 % | No |
| 3상 결과 | 2 | 0.873 % | No |
| 밝혔다 이번 | 2 | 0.873 % | No |
| ECCMID서 ‘렉키로나’ | 2 | 0.873 % | No |
| PDC 개발 | 2 | 0.873 % | No |
| 임상 3상 | 2 | 0.873 % | No |
| 'KIT 항체' | 2 | 0.873 % | No |
| 항체' 만성두드러기 | 2 | 0.873 % | No |
| 셀덱스 'KIT | 2 | 0.873 % | No |
| 이를 통해 | 2 | 0.873 % | No |
| 세포·유전자 치료제 | 2 | 0.873 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| FDA 얀센 '코로나19 백신' | 2 | 0.873 % | No |
| 얀센 '코로나19 백신' 갈랑바레증후군 | 2 | 0.873 % | No |
| '코로나19 백신' 갈랑바레증후군 발생 | 2 | 0.873 % | No |
| 아이오니스 Bicycle 'TfR1 전달기술' | 2 | 0.873 % | No |
| 고군분투 아이오니스 Bicycle 'TfR1 | 2 | 0.873 % | No |
| 만성두드러기 1b상 완전관해 95 | 2 | 0.873 % | No |
| 항체' 만성두드러기 1b상 완전관해 | 2 | 0.873 % | No |
| 셀덱스 'KIT 항체' 만성두드러기 | 2 | 0.873 % | No |
| 백신' 갈랑바레증후군 발생 경고 | 2 | 0.873 % | No |
| Bicycle 'TfR1 전달기술' 사들여 | 2 | 0.873 % | No |
| 글로벌 딜셀렉타 OHPAS 적용 | 2 | 0.873 % | No |
| 딜셀렉타 OHPAS 적용 PDC | 2 | 0.873 % | No |
| OHPAS 적용 PDC 개발 | 2 | 0.873 % | No |
| 첫 글로벌 딜셀렉타 OHPAS | 2 | 0.873 % | No |
| 인투셀 첫 글로벌 딜셀렉타 | 2 | 0.873 % | No |
| 제넥신 성영철 회장 대표·이사회서 | 2 | 0.873 % | No |
| 성영철 회장 대표·이사회서 물러난다 | 2 | 0.873 % | No |
| 아두헬름 '초기 AD환자로' 라벨 | 2 | 0.873 % | No |
| 'KIT 항체' 만성두드러기 1b상 | 2 | 0.873 % | No |
| 논란의 아두헬름 '초기 AD환자로' | 2 | 0.873 % | No |
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Wed, 14 Jul 2021 14:49:50 GMT
cache-control: no-cache
Content-Encoding: gzip
Vary: Accept-Encoding
Connection: close
Transfer-Encoding: chunked
Content-Type: text/html; charset=UTF-8
Domain Information
| Domain Registrar: |
Whois Corp.
|
|---|---|
| Registration Date: | 2016-02-24 8 years 8 months 3 weeks ago |
| Last Modified: | 2019-01-15 5 years 10 months 1 week ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns1.nidc.kr | |
222.122.43.197 | South Korea |
| ns2.nidc.kr | |
222.122.43.198 | South Korea |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| biospectator.com | A | 10713 |
IP: 112.175.173.118 |
| biospectator.com | NS | 10800 |
Target: ns1.nidc.kr |
| biospectator.com | NS | 10800 |
Target: ns2.nidc.kr |
| biospectator.com | NS | 10800 |
Target: ns1-slave.nidc.kr |
| biospectator.com | SOA | 10800 |
MNAME: ns1.nidc.kr RNAME: www.nidc.kr Serial: 2016042810 Refresh: 10800 Retry: 1800 Expire: 1209600 |
| biospectator.com | MX | 10800 |
Priority: 10 Target: mail.biospectator.com |
| biospectator.com | TXT | 10800 |
TXT: v=spf1 ip4:112.175.173.96 ip4:211.234.116.207 ~all |
Full WHOIS Lookup
Registry Domain ID:
2005915631_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.whois.co.kr
Registrar URL:
http://www.whois.co.kr
Updated Date:
2019-01-15T02:18:38Z
Creation Date:
2016-02-24T07:43:55Z
Registry Expiry Date:
2024-02-24T07:43:55Z
Registrar: Whois Corp.
Registrar IANA ID:
100
Registrar Abuse Contact Email: [email protected]
Registrar
Abuse Contact Phone: +82.15884259
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
NS1.NIDC.KR
Name Server: NS2.NIDC.KR
DNSSEC: unsigned
URL
of the ICANN Whois Inaccuracy Complaint Form:
https://www.icann.org/wicf/
>>> Last update of whois database:
2021-07-14T14:51:05Z
Similarly Ranked Websites
PressReleasePoint | Free Press Release Distribution Website
Free press release website for online press release distribution to social media and news media. Submit paid and free press release.
259,852 
$ 35,640.00
Đài phát thanh và truyền hình Hà Nội
Tin tức, video nổi bật, radio, truyền hình trực tuyến
259,853 $ 35,640.00
Study Lecture Notes
All in One Solution for your Studies
259,859 $ 35,640.00
Merinews | Largest citizen journalism based news platform in India
merinews.com, citizen journalism based news platform. Media platform for citizen journalists in India and across the globe.
259,860 $ 35,640.00